JP2006508332A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508332A5
JP2006508332A5 JP2004507519A JP2004507519A JP2006508332A5 JP 2006508332 A5 JP2006508332 A5 JP 2006508332A5 JP 2004507519 A JP2004507519 A JP 2004507519A JP 2004507519 A JP2004507519 A JP 2004507519A JP 2006508332 A5 JP2006508332 A5 JP 2006508332A5
Authority
JP
Japan
Prior art keywords
ppsa
psa
total
amount
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004507519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508332A (ja
Filing date
Publication date
Priority claimed from US10/154,715 external-priority patent/US20030219840A1/en
Application filed filed Critical
Publication of JP2006508332A publication Critical patent/JP2006508332A/ja
Publication of JP2006508332A5 publication Critical patent/JP2006508332A5/ja
Pending legal-status Critical Current

Links

JP2004507519A 2002-05-24 2003-05-22 前立腺癌検出改善のための血清中前立腺特異抗原プロ酵素型の分析方法。 Pending JP2006508332A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/154,715 US20030219840A1 (en) 2002-05-24 2002-05-24 Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection
PCT/US2003/016148 WO2003100079A2 (en) 2002-05-24 2003-05-22 Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection

Publications (2)

Publication Number Publication Date
JP2006508332A JP2006508332A (ja) 2006-03-09
JP2006508332A5 true JP2006508332A5 (https=) 2006-05-18

Family

ID=29548943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004507519A Pending JP2006508332A (ja) 2002-05-24 2003-05-22 前立腺癌検出改善のための血清中前立腺特異抗原プロ酵素型の分析方法。

Country Status (5)

Country Link
US (1) US20030219840A1 (https=)
EP (1) EP1506401A4 (https=)
JP (1) JP2006508332A (https=)
CN (1) CN1656379A (https=)
WO (1) WO2003100079A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009111878A1 (en) * 2008-03-11 2009-09-17 Axela Inc. Quantification and affinity characterization of antibodies for the diagnosis of disease using optical diffraction
CN103134929A (zh) * 2011-12-02 2013-06-05 沃克(天津)生物科技有限公司 游离前列腺特异抗原与总前列腺特异抗原一体化酶联免疫检测试剂盒及检测方法
CN102520161A (zh) * 2012-01-05 2012-06-27 中南大学 一种用于spr双通道法检测前列腺特异性抗原的生物传感芯片、试剂盒，检测方法
JP2015524052A (ja) 2012-05-16 2015-08-20 ファディア・アクチボラゲットＰｈａｄｉａ ＡＢ 前立腺癌の存在または不存在の提示方法
KR20150110477A (ko) 2012-11-20 2015-10-02 파디아 에이비 공격적인 전립선 암의 존재 또는 부존재를 나타내는 방법
CN104007256A (zh) * 2013-02-21 2014-08-27 林斯 总psa和游离psa二合一化学发光免疫诊断试剂盒的制备方法
AU2015230017B2 (en) 2014-03-11 2021-06-17 A3P Biomedical Ab Method for detecting a solid tumor cancer
CN105929151A (zh) * 2016-06-30 2016-09-07 深圳市亚辉龙生物科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法
JP7138112B2 (ja) 2017-02-01 2022-09-15 ファディア・アクチボラゲット 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法
CN111596060A (zh) * 2020-05-19 2020-08-28 迪瑞医疗科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2286090C (en) * 1997-04-30 2013-01-08 Hybritech Incorporated Forms of prostate specific antigen and methods for their detection
US7659073B2 (en) * 1997-04-30 2010-02-09 Hybritech Incorporated Forms of prostate specific antigens and methods for their detection
US7211397B2 (en) * 1999-04-30 2007-05-01 Beckman Coulter, Inc. Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
EP1290032B1 (de) * 2000-05-24 2006-08-09 Roche Diagnostics GmbH Antikörper gegen spezielle formen des propsa und deren verwendung in immunoassays

Similar Documents

Publication Publication Date Title
JP2011510309A5 (https=)
JP2008536125A5 (https=)
JP6397822B2 (ja) デバイスおよびアミノアシドパシーの検出のためにデバイスを用いる方法
JP2006508332A5 (https=)
WO2006081521A3 (en) Methods for diagnosis and intervention of hepatic disorders
MA29282B1 (fr) Procede de diagnostic d'une steatose hepatique au moyen de marqueurs biochimiques
MX2009002830A (es) Sistema biosensor que tiene estabilidad y desempeño de hematocrito mejorados.
WO2001061043A3 (en) Parallel genotyping of multiple patient samples
EP2306192A3 (en) Risk Markers For Cardiovascular Disease
CY1109638T1 (el) Ενα συστημα ή μεθοδος για την εκτιμηση της περιφερειακης κυκλοφοριας του αιματος ενος υποκειμενου
JP2009528544A5 (https=)
CA2798562A1 (en) Methods and compositions for the diagnosis and treatment of thyroid cancer
WO2006103570A3 (en) Diagnosis method of alcoholic or non-alcoholic steato-hepatitis using biochemical markers
ATE532063T1 (de) Elektrochemischer biosensor
WO2003100006A3 (en) Method of improved prostate cancer detection
WO2009128960A3 (en) Rapid test including genetic sequence probe
WO2007001402A3 (en) Redox potential mediated, heterogeneous, carbon nanotube biosensing
WO2008020823A3 (en) Cooperative reporter systems, components, and methods for analyte detection
CN104359906B (zh) 一种稳定、抗干扰能力强的血清总胆汁酸检测试剂
CN104777194A (zh) 抗干扰传感电极及微流控试纸流道流速控制方法
EP1437591A4 (en) KITS FOR THE DIAGNOSIS OF KIDNEY DISEASES
CA2623653A1 (en) Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
JP2010500535A5 (https=)
WO2003100079A3 (en) Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection